Literature DB >> 23303687

Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.

Jiun-Jen Lynn1, Kuan-Fu Chen, Yi-Ming Weng, Te-Fa Chiu.   

Abstract

Febrile neutropenia caused by chemotherapy is a frequent medical emergency associated with severe complications in the emergency department (ED). Timely administration of antibiotics is believed to improve patient outcomes for several infectious diseases such as pneumonia and sepsis but has not been thoroughly evaluated for reducing risk of complications in chemotherapy-induced febrile neutropenia. The aim of this study was to evaluate associations between the risk factors and serious complications in patients presenting to the ED with febrile neutropenia. We reviewed the health information system database to identify a retrospective cohort of patients with febrile neutropenia who visited the ED of a tertiary medical hospital from January to December 2008. Only episodes of febrile neutropenia caused by chemotherapy for underlying cancer were included. Serious complications during hospitalization were defined as unstable hemodynamic status, respiratory distress, altered mental status, newly developed arrhythmia that required intervention, and death during hospitalization. Univariate and multivariate logistic regression analysis was performed to determine potential factors associated with serious complications. We further use decision tree approach to help analyze variables. Among a total of 81 febrile neutropenic episodes in 78 patients, 25 (30.8%) episodes of serious complications were identified. Latency of the first dose of antibiotics, pneumonia and platelet counts ≤ 50,000/mm(3) were identified as independent factors associated with serious complications of febrile neutropenia. Earlier administration of antibiotics is associated with fewer complications in patients presenting to the ED with febrile neutropenia.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  antibiotics; chemotherapy; complications; febrile neutropenia; prediction; risk factors

Mesh:

Substances:

Year:  2013        PMID: 23303687     DOI: 10.1002/hon.2040

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  19 in total

1.  Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.

Authors:  Byuk Sung Ko; Shin Ahn; Yoon-Seon Lee; Won Young Kim; Kyung Soo Lim; Jae-Lyun Lee
Journal:  Support Care Cancer       Date:  2015-02-10       Impact factor: 3.603

2.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.

Authors:  Christa Koenig; Christine Schneider; Jessica E Morgan; Roland A Ammann; Lillian Sung; Bob Phillips
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

Review 3.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

4.  The Emergency Care of Patients With Cancer: Setting the Research Agenda.

Authors:  Jeremy Brown; Corita Grudzen; Demetrios N Kyriacou; Ziad Obermeyer; Tammie Quest; Donna Rivera; Susan Stone; Jason Wright; Nonniekaye Shelburne
Journal:  Ann Emerg Med       Date:  2016-02-26       Impact factor: 5.721

Review 5.  Pneumonia in the neutropenic cancer patient.

Authors:  Scott E Evans; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2015-05       Impact factor: 3.155

6.  Chemotherapy-induced neutropenia among pediatric cancer patients in Egypt: Risks and consequences.

Authors:  Mohamed Badr; Tamer Hassan; Hanan Sakr; Nehad Karam; Doaa Abdel Rahman; Doaa Shahbah; Marwa Zakaria; Sahbaa Fehr
Journal:  Mol Clin Oncol       Date:  2016-07-12

7.  Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.

Authors:  Shin Ahn; Terry W Rice; Sai-Ching J Yeung; Tim Cooksley
Journal:  Support Care Cancer       Date:  2017-11-22       Impact factor: 3.603

8.  Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay.

Authors:  Matilde Boada Burutaran; Regina Guadagna; Sofia Grille; Mariana Stevenazzi; Cecilia Guillermo; Lilian Diaz
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-21

9.  Machine Learning for Early Warning of Septic Shock in Children With Hematological Malignancies Accompanied by Fever or Neutropenia: A Single Center Retrospective Study.

Authors:  Long Xiang; Hansong Wang; Shujun Fan; Wenlan Zhang; Hua Lu; Bin Dong; Shijian Liu; Yiwei Chen; Ying Wang; Liebin Zhao; Lijun Fu
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

Review 10.  Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).

Authors:  Olaf Penack; Carolin Becker; Dieter Buchheidt; Maximilian Christopeit; Michael Kiehl; Marie von Lilienfeld-Toal; Marcus Hentrich; Marc Reinwald; Hans Salwender; Enrico Schalk; Martin Schmidt-Hieber; Thomas Weber; Helmut Ostermann
Journal:  Ann Hematol       Date:  2014-04-29       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.